Clinical-stage medical device company further strengthens its intellectual property position with a new patent from the USPTO for FastWave’s advanced intravascular lithotripsy (IVL) technology.
, /PRNewswire-PRWeb/ — FastWave Medical, a leading developer in advanced intravascular lithotripsy (IVL) technology, announced the issuance of its sixth utility patent by the United States Patent and Trademark Office (USPTO). This is the fourth patent the company has been granted this year. This latest addition to the company’s growing intellectual property portfolio reinforces FastWave’s position in the exciting IVL field.
I’m particularly excited about the potential of FastWave’s IVL devices in critical areas like catheter deliverability and energy durability.
FastWave Medical’s IVL systems are designed to address a condition that affects millions of people worldwide: calcified arteries. Vessels burdened with calcium pose significant challenges in treating vascular blockages safely and efficiently. FastWave aims to empower physicians with breakthrough IVL devices to navigate complex arterial disease more effectively, reduce complications, and enhance overall …